Dying at home: The problem hospices have with stolen opioids

Synthesized from U.S. guidance, reporting, and peer-reviewed research on hospice care, opioid safety, diversion, and medication disposal.

For many Americans, dying at home is the good ending to a hard story. It means familiar walls, familiar voices, maybe a dog on the bed, maybe a grandkid in the next room, and a lot fewer fluorescent lights. Hospice exists to make that kind of death more comfortable by focusing on pain relief, breathlessness, anxiety, and dignity rather than cure.

But home hospice has a modern problem that does not fit neatly into the soft language of comfort care: stolen opioids.

The irony is brutal. The same medications that can relieve severe pain and ease the frightening sensation of air hunger near the end of life can also attract misuse, diversion, theft, and panic. In a hospital, controlled drugs live behind locked systems and layers of documentation. In a private home, they may live in a kitchen drawer next to expired soy sauce packets and a mystery takeout menu from 2022. That is not exactly Fort Knox.

This is the tension at the heart of the issue. Hospices need opioids because some dying patients genuinely need opioids. Yet the more end-of-life care shifts into the home, the more controlled substances shift into spaces that were never designed to function like miniature pharmacies. Add grief, family conflict, addiction history, overworked caregivers, and patchy disposal laws, and you get a serious public health problem hiding inside a compassionate model of care.

Why opioids matter so much in hospice care

Before talking about theft, it is worth saying something plainly: opioids are not the villain of hospice. In many cases, they are a critical tool of humane care.

People in hospice may experience severe cancer pain, bone pain, nerve pain, and the kind of shortness of breath that makes every inhale feel like bad news. Medications such as morphine and hydromorphone are often used because they can reduce suffering quickly and effectively. In end-of-life care, the goal is not to tough it out. The goal is comfort, function, and peace.

That reality is one reason this topic gets emotionally tangled. Families may already be nervous about opioids because of the broader opioid crisis. Some worry about addiction, overdose, sedation, or “giving too much.” Others fear the exact opposite: that the patient will suffer because everyone is too scared to medicate pain appropriately. Hospice teams often walk a narrow line between education and reassurance, trying to explain that a medication can be both necessary and dangerous depending on how it is handled.

In other words, the drug itself is not the whole story. Context is everything. In hospice, opioids can be compassionate medicine. In the wrong hands, they can become contraband, temptation, or tragedy.

Why the home is uniquely vulnerable

Hospice at home sounds simple on paper. In reality, it is a complicated ecosystem. A patient may have a spouse, adult children, paid aides, neighbors, friends from church, visiting nurses, delivery drivers, and sometimes a rotating cast of relatives who appear with casseroles and opinions. That is a lot of human traffic around a lot of very powerful medication.

The medicine is accessible

Unlike inpatient settings, private homes rarely have secure medication systems. A bottle of liquid morphine may sit on a bedside table. A fentanyl patch may be changed by a family member with little clinical training. A “comfort kit” may include controlled medications that are not needed immediately but are kept on hand in case symptoms escalate. Convenience for symptom control can also mean convenience for theft.

The caregiving environment is stressful

Home caregivers are often exhausted, grieving, and overwhelmed. They may be learning medication administration on the fly while also managing bathing, feeding, appointments, and family conflict. That is not a criticism. It is reality. Grief is not an ideal compliance program.

Some households already have addiction risk

Research and hospice guidance increasingly recognize that diversion risk does not always come from strangers. It may come from family members, frequent visitors, or others in the home with a history of substance misuse. That makes the problem much harder to discuss because it collides with trust, shame, denial, and fear of judgment. Asking, “Who in this house might steal medication from a dying person?” is clinically necessary and emotionally explosive.

Symptoms can mask theft

When a hospice patient’s pain is uncontrolled, there are many possible explanations: disease progression, underdosing, poor absorption, a dosing mistake, or medication diversion. That means theft may not be obvious at first. A patient who keeps crying out in pain may trigger dose increases or refills, while the real problem is that the medication is disappearing before it ever reaches the patient.

The real-world problem is bigger than many people think

This is not just a theoretical risk discussed in policy meetings and continuing education sessions over stale muffins.

Peer-reviewed U.S. survey research has found that missing opioid medications are not rare in hospice operations. In one national survey of randomly selected hospices, 43% of hospice representatives said missing opioid medications had occurred within the previous 90 days. The same study found that 52% said employees were not allowed to dispose of medications after a home death, and unused opioids were left in the home roughly 32% of the time after home hospice deaths.

Those numbers matter because leftover opioids do not simply vanish into a cloud of paperwork and good intentions. They remain in houses, apartments, medicine cabinets, purses, drawers, and lockboxes. And once the patient dies, the medications may no longer have a clear medical purpose, but they still carry street value, misuse potential, and overdose risk.

Reporting has also documented real examples of diversion in home hospice settings: neighbors stealing painkillers, family members “losing” medications, paid caregivers taking opioids, and even clinicians accused or convicted of diverting drugs meant for dying patients. These are not the majority of hospice encounters, but they are serious enough to show the problem is not hypothetical. It is operational, ethical, and ongoing.

What hospices are required to do

Federal hospice rules do not ignore this issue. In fact, CMS guidance makes clear that hospices must have written policies and procedures for the safe management and disposal of controlled drugs in the patient’s home. When controlled drugs are first ordered, the hospice is expected to provide those policies, discuss them with the patient or representative and family in language they understand, and document that the conversation happened.

CMS guidance also says the patient’s plan of care should identify whether the patient or family is self-administering medications. If they are not capable of safely handling drugs in the home, the hospice must address that in the care plan. That is an important point. Safe medication management is not a side quest. It is part of the care plan itself.

Professional guidance goes further. Hospice and palliative care experts recommend a kind of “universal precautions” mindset around diversion prevention. That includes educating families on secure storage and disposal, screening for addiction risk in the household, monitoring medications through pill counts or liquid checks, investigating missing drugs, documenting concerns, identifying one trusted person to manage medications, limiting supply when needed, and using lockboxes or self-dispensing devices in higher-risk situations.

So, on paper, the system is not asleep. The challenge is execution in real homes with real people under real stress.

Why disposal is such a mess after death

If this problem were easy, the solution would be obvious: once the patient dies, get rid of the unused opioids immediately and safely.

That is also where things get messy.

DEA rules have expanded disposal options over time, including authorized collectors and take-back programs. FDA guidance says the best option for most unused medicines is a take-back location or mail-back envelope. If that is not available, some drugs on the FDA flush list should be flushed, and others should be mixed with something undesirable like used coffee grounds, dirt, or cat litter and discarded in household trash.

Sounds reasonable. In practice, it can be awkward, confusing, and delayed.

Families may not know the rules. They may be in shock. They may not want to deal with pill bottles while funeral plans are being made. They may disagree about what should happen. In some states, hospice staff may educate and supervise, but they cannot directly destroy the medication themselves unless state law allows it. That creates a strange gap between responsibility and authority. Everyone agrees the drugs should leave the home. Not everyone is legally empowered to make that happen in the most straightforward way.

And the longer those drugs stay put, the more likely they are to be diverted, shared, stolen, or forgotten until someone finds them months later while looking for batteries.

How stolen opioids hurt patients and families

The patient suffers first

When medications are stolen, the patient may experience uncontrolled pain or breathlessness. That is the most immediate harm, and it is morally serious. A dying person should not be left suffering because somebody else saw an opportunity in a bottle of morphine.

Families are pulled into suspicion

Diversion can turn a bedside vigil into an informal investigation. Who had access? Who handled the comfort kit? Why is the liquid level lower than it should be? Why are early refills needed? Families already strained by anticipatory grief can fracture further under suspicion.

Caregivers carry fear and shame

Hospice research has shown that caregivers feel the weight of managing opioids in the home. Some fear theft. Some fear making a dosing mistake. Some fear being judged for having controlled drugs in the house. These worries can lead to hesitation in giving appropriate doses, which can increase suffering even when no diversion occurs.

Communities absorb the downstream risk

Unused opioids left in the home are not just a family issue. They become a broader safety problem. FDA messaging has emphasized that keeping unused opioids at home creates risk if they are taken by someone they were not prescribed for, especially children, pets, or people seeking drugs. Many people who misuse prescription pain medicines get them from friends or family members, which means the home remains a key entry point in the misuse pipeline.

What better hospice opioid stewardship looks like

The answer is not to under-treat pain. It is to treat pain well while managing risk like adults who understand both medicine and human nature.

1. Start the conversation early

Medication safety should not be introduced only after something goes wrong. Hospices should explain, at admission and again when controlled drugs are ordered, how opioids will be stored, who will manage them, how doses will be tracked, and what will happen to leftovers after death.

2. Name one medication manager

When everyone is in charge, no one is in charge. A single trusted caregiver should be identified whenever possible to track dosing, supplies, and storage.

3. Normalize risk screening

Screening for addiction risk in the household should be routine, not accusatory. The point is not to shame families. The point is to prevent avoidable harm.

4. Use practical controls

Lockboxes, smaller prescription quantities, pill counts, liquid measurement checks, patch tracking, and clear documentation are not signs of mistrust. They are signs that hospice teams understand the environment they are working in.

5. Make disposal easier, not vague

Families need concrete instructions, not hand-wavy advice. “Dispose of these safely” is not enough. Hospices should explain the available take-back, mail-back, flush-list, and household disposal options, and where state law allows, supervise prompt disposal after death.

6. Document and investigate missing meds fast

If medications go missing, hospice teams should investigate, document, communicate internally, and adjust the care plan. That may mean changing who has access, increasing monitoring, or relocating care if safety cannot be maintained.

Experience and perspective: what this looks like in real homes

Talk to enough hospice clinicians, and a pattern emerges. The opioid problem at home almost never arrives with dramatic music and a neon sign that says diversion happening here. It usually shows up as something small, slippery, and easy to rationalize.

A patient says the pain medicine is not working anymore. A daughter says the bottle tipped over. A son says he is sure there were more pills yesterday. A nurse notices that the liquid morphine looks lower than expected, but the family has been up for three nights in a row and nobody is charting doses carefully. A paid aide seems a little too interested in where the lockbox key is kept. A relative with a rough history appears out of nowhere and suddenly wants to “help with caregiving.”

These situations are not always theft. Sometimes they are confusion, poor teaching, or plain old exhaustion. That is exactly what makes the problem so difficult. Hospice teams are trained to lead with compassion, not suspicion. Families are trying to survive one of the worst weeks of their lives, not pass an exam in controlled-substance stewardship. And yet the medication still needs to be accounted for, because the patient is depending on it.

Many families describe the same emotional whiplash. They want the medications nearby because symptoms can change quickly. They also do not want them nearby because the drugs feel scary, powerful, and morally heavy. Some are worried about teenagers in the home. Some are worried about an estranged relative. Some are quietly worried about themselves. In that sense, the hospice opioid issue is not just a pharmacy issue. It is a family systems issue, a trust issue, and a grief issue wrapped into one.

Clinicians often learn that the most effective interventions are the least glamorous. Label the syringe clearly. Count the pills. Keep the bottle in one place. Do not let six people administer medication. Re-teach the dosing schedule. Ask directly whether anyone in the house has a history of substance misuse. Repeat disposal instructions. Write everything down. Say the uncomfortable thing kindly, early, and without drama.

Families who get through this well often say the same thing afterward: they needed more clarity than they expected. Not more jargon. More clarity. They wanted someone to tell them, step by step, what the medicine was for, how to give it, where to keep it, what warning signs to watch for, and exactly what to do with what was left after death. In moments of grief, vagueness feels like abandonment.

The hardest part is that hospice is supposed to make dying at home feel less clinical, less institutional, and more human. That is a beautiful goal. But the opioid crisis has made it impossible to pretend that a home is just a home when controlled substances are involved. Sometimes the most compassionate thing a hospice can do is bring a little more structure into the living room. Not because families are bad. Because they are human.

Conclusion

Dying at home remains one of the most meaningful forms of end-of-life care in the United States. It can be intimate, peaceful, and deeply dignified. But it is not automatically safe just because it is loving.

Hospices now operate at the crossroads of palliative medicine and the opioid crisis. They must relieve pain without feeding diversion, trust families without ignoring risk, and move quickly enough to comfort dying patients while carefully enough to protect everyone else in the home. That is a hard assignment, but it is not impossible.

The best hospice programs understand the truth that policy alone cannot fix: stolen opioids are not just a drug problem. They are a systems problem. A communication problem. A disposal problem. A grief problem. And sometimes, heartbreakingly, a family problem.

Better screening, better education, better documentation, better disposal practices, and more realistic expectations about what happens inside homes can reduce the risk. Most of all, hospice needs to keep doing two things at once: treating suffering seriously and treating opioid stewardship seriously. The patient deserves both.